These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38401524)

  • 1. Mechanism insights into the pleiotropic effects of nobiletin as a potential therapeutic agent on non-alcoholic fatty liver disease (NAFLD).
    Ran Q; Gan Q; Zhu Y; Song L; Shen L; Duan X; Zhu X; Huang W
    Biomed Pharmacother; 2024 Apr; 173():116322. PubMed ID: 38401524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress of research on the role of active ingredients of Citri Reticulatae Pericarpium in liver injury.
    Gao S; Chen X; Yu Z; Du R; Chen B; Wang Y; Cai X; Xu J; Chen J; Duan H; Cai Y; Zheng G
    Phytomedicine; 2023 Jul; 115():154836. PubMed ID: 37119760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91
    Bunbupha S; Pakdeechote P; Maneesai P; Prasarttong P
    J Nutr Biochem; 2021 Jan; 87():108526. PubMed ID: 33096235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nobiletin mitigates NAFLD
    Yang X; Deng Y; Tu Y; Feng D; Liao W
    Food Funct; 2022 Oct; 13(19):10186-10199. PubMed ID: 36111578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.
    Kim YJ; Choi MS; Woo JT; Jeong MJ; Kim SR; Jung UJ
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28116779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
    Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
    J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.
    Liu C; Liao JZ; Li PY
    World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Effect of Fuzi Lizhong Decoction against Non-alcoholic Fatty Liver Disease via Anti-inflammatory Response through Regulating p53 and PPARG Signaling.
    Yang J; Ma W; Mei Q; Song J; Shu L; Zhang S; Li C; An L; Du N; Shi Z
    Biol Pharm Bull; 2020; 43(11):1626-1633. PubMed ID: 33132309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.
    Gong P; Long H; Guo Y; Wang Z; Yao W; Wang J; Yang W; Li N; Xie J; Chen F
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116927. PubMed ID: 37532073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science.
    Zhang S; Wong YT; Tang KY; Kwan HY; Su T
    Front Endocrinol (Lausanne); 2020; 11():572729. PubMed ID: 33101207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin Ameliorates Hepatic Lipid Deposition, Oxidative Stress, and Inflammation by Mechanisms That Involve the Nrf2/NF-κB Axis in Nonalcoholic Fatty Liver Disease.
    Fan C; Ling-Hu A; Sun D; Gao W; Zhang C; Duan X; Li H; Tian W; Yu Q; Ke Z
    J Agric Food Chem; 2023 Dec; 71(50):20105-20117. PubMed ID: 38073108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress on therapeutic targets of active components in Chinese herbs for treatment of nonalcoholic fatty liver disease].
    Pan YT; Xu FY; Yu XZ; Shang WB
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1109-1112. PubMed ID: 29027424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.
    Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y
    Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal medicines and nonalcoholic fatty liver disease.
    Yao H; Qiao YJ; Zhao YL; Tao XF; Xu LN; Yin LH; Qi Y; Peng JY
    World J Gastroenterol; 2016 Aug; 22(30):6890-905. PubMed ID: 27570425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin.
    Xu H; Yuan M; Niu K; Yang W; Jiang M; Zhang L; Zhou J
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nobiletin in improving hypercholesterolemia and nonalcoholic fatty liver disease in high-cholesterol diet-fed mice.
    Kim YJ; Yoon DS; Jung UJ
    Nutr Res Pract; 2021 Aug; 15(4):431-443. PubMed ID: 34349877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
    Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.